GlobalData on MSN
MHRA outlines upcoming IVD submission shift for clinical trials
From 28 April, IVDs used clinical trials will be subject to an upfront assessment by the MHRA as part of a Clinical Trial of an Investigational Medicinal Product submission.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results